These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9017526)

  • 1. Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: a pilot study.
    van Dyck CH; McMahon TJ; Rosen MI; O'Malley SS; O'Connor PG; Lin CH; Pearsall HR; Woods SW; Kosten TR
    J Neuropsychiatry Clin Neurosci; 1997; 9(1):29-36. PubMed ID: 9017526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process.
    Harel Y; Appleboim N; Lavie M; Achiron A
    J Neurol Sci; 2009 Jan; 276(1-2):38-40. PubMed ID: 18817930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.
    Konstenius M; Jayaram-Lindström N; Beck O; Franck J
    Drug Alcohol Depend; 2010 Apr; 108(1-2):130-3. PubMed ID: 20015599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
    Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM
    J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.
    Levin FR; Evans SM; Brooks DJ; Kalbag AS; Garawi F; Nunes EV
    Drug Alcohol Depend; 2006 Feb; 81(2):137-48. PubMed ID: 16102908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate enhances cognitive performance in adults with poor baseline capacities regardless of attention-deficit/hyperactivity disorder diagnosis.
    Agay N; Yechiam E; Carmel Z; Levkovitz Y
    J Clin Psychopharmacol; 2014 Apr; 34(2):261-5. PubMed ID: 24525641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of methylphenidate in the rehabilitation of attention following traumatic brain injury: a randomised, crossover, double blind, placebo controlled inpatient trial.
    Willmott C; Ponsford J
    J Neurol Neurosurg Psychiatry; 2009 May; 80(5):552-7. PubMed ID: 19060022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate improves HIV-1-associated cognitive slowing.
    Hinkin CH; Castellon SA; Hardy DJ; Farinpour R; Newton T; Singer E
    J Neuropsychiatry Clin Neurosci; 2001; 13(2):248-54. PubMed ID: 11449032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of methylphenidate on cognition and apathy in normal pressure hydrocephalus: a case study and review.
    Keenan S; Mavaddat N; Iddon J; Pickard JD; Sahakian BJ
    Br J Neurosurg; 2005 Feb; 19(1):46-50. PubMed ID: 16147583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive Improvement of Attention and Inhibition in the Late Afternoon in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Treated With Osmotic-Release Oral System Methylphenidate.
    Slama H; Fery P; Verheulpen D; Vanzeveren N; Van Bogaert P
    J Child Neurol; 2015 Jul; 30(8):1000-9. PubMed ID: 25296928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A; Richard C; Prinzo R; Binder C
    Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of armodafinil on cognition in patients with HIV/AIDS and fatigue.
    McElhiney M; Rabkin J; Van Gorp W; Rabkin R
    J Clin Exp Neuropsychol; 2013; 35(7):718-27. PubMed ID: 23944194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
    Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
    Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate: established and expanding roles in symptom management.
    Prommer E
    Am J Hosp Palliat Care; 2012 Sep; 29(6):483-90. PubMed ID: 22144657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
    Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P
    J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
    Lee H; Kim SW; Kim JM; Shin IS; Yang SJ; Yoon JS
    Hum Psychopharmacol; 2005 Mar; 20(2):97-104. PubMed ID: 15641125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic closed head injury with psychostimulant drugs: a controlled case study and an appropriate evaluation procedure.
    Evans RW; Gualtieri CT; Patterson D
    J Nerv Ment Dis; 1987 Feb; 175(2):106-10. PubMed ID: 3543216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.